Skip to main content

Weei-chin Lin

FY2026 NIH rank #10,037
  • R01 Holder
  • Early Career
  • Mentor
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 6865445Search this ID in NIH RePORTER
ORCID iD
https://orcid.org/0000-0002-6804-3205Verified identifier for this researcher
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Anatomy & Cell Biology
  • Internal Medicine

NIH Funding · FY2026

Linked Award Amount
$2M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#10,037
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Weei-chin Lin. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCI

National Cancer Institute

$1.2M

3 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Weei-chin Lin as a PI. Multi-PI records show the full award amount for context.

  • 5T32GM136560-07T32
    Training Program in Cell and Molecular Biology
    $862.7K
    award amount
  • 1R21CA312323-01R21
    Targeting Convergent Pathways to Overcome Osimertinib Resistance in EGFR-Mutated Lung Cancer
    $411.4K
    award amount
  • 5R01CA203824-10R01
    Novel therapeutics for targeting checkpoint dysfunction in cancer
    $382.5K
    award amount
  • 5R01CA269971-04R01
    14-3-3tau drives estrogen receptor loss and breast cancer progression
    $366K
    award amount

Award organization

Organizations that administered FY2026 awards listing Weei-chin Lin as a PI.

FY2026 award administered by Baylor College of Medicine (TX).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Baylor College of Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    Entered Top 50% Nationally
    Ranked #9213
  6. 2025
    R01 Grant Holder